| N-(5-tert-Butylisoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea |
奎扎替尼 |
950769-58-1 |
| 4-AMino-5-Methylpyridin-2-ol |
4-氨基-5-甲基-2-羟基吡啶 |
95306-64-2 |
| INDEX NAME NOT YET ASSIGNED |
(R)-3-环戊基-3-肼基丙腈-L-酒石酸盐 |
2761879-36-9 |
| 1-Piperazineacetamide, N-[trans-4-(acetylamino)cyclohexyl]-4-[5-(4-methylphenyl)-1,2,4-triazin-3-yl]- |
化合物 LORUNDROSTAT |
1820940-17-7 |
| BMS-986165 |
BMS-986165 |
1802425-99-5 |
| Remibrutinib |
LOU-064 |
1787294-07-8 |
| Mavacamten |
玛伐凯泰 |
1642288-47-8 |
| Povorcitinib |
INCB54707 |
1637677-22-5 |
| 4-Morpholinecarboxylic acid, 2-[[2-[2,6-difluoro-4-[(methylamino)carbonyl]phenyl]-7-methylimidazo[1,2-a]pyridin-3-yl]methyl]-, methyl ester, (2S)- |
BLU-5937 |
1621164-74-6 |
| Baxdrostat |
BAXDROSTAT |
1428652-17-8 |
| [5-Methanesulfonyl-2-((R)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-[(1R,5R)-1-(5-trifluoromethyl-isoxazol-3-yl)-3-aza-bicyclo[3.1.0] |
BI-425809 |
1421936-85-7 |
| Cilofexor |
CILOFEXOR; GS-9674; GS 9674; GS9674; |
1418274-28-8 |
| Lemborexant |
莱博雷生 |
1369764-02-2 |
| Benzonitrile, 2-chloro-4-[(3S,3aR)-3-cyclopentyl-3,3a,4,5-tetrahydro-7-[(4-hydroxy-1-piperidinyl)carbonyl]-2H-pyrazolo[3,4-f]quinolin-2-yl]- |
OCEDURENONE |
1359969-24-6 |
| {(1R,2R,4R)-4-[(tert-butoxycarbonyl)-amino]-2-hydroxy-cyclohexyl} benzene-carbothioate |
{(1R,2R,4R)-4-[(叔丁氧羰基)-氨基]-2-羟基环己基}苯硫代酯 |
1350636-89-3 |
| 2(3H)-Benzoxazolone, 5-[[2-[(4-fluoro-3-methoxy-5-methylphenyl)amino]-5-methyl-4-pyrimidinyl]amino]- |
IFIDANCITINIB |
1236667-40-5 |
| lumateperone (Tosylate) |
1-(4-氟苯基)-4-[(6BR,10AS)-2,3,6B,9,10,10A-六氢-3-甲基-1H-吡啶并[3',4':4,5]吡咯并[1,2,3-DE]喹喔啉-8(7H)-基]-1-丁酮对甲苯磺酸盐 |
1187020-80-9 |
| ACT-132577 |
N-[5-(4-溴苯基)-6-[2-[(5-溴-2-嘧啶基)氧基]乙氧基]-4-嘧啶基]氨基磺酰胺 |
1103522-45-7 |
| Tenapanor |
CS-2459 |
1234423-95-0 |
| 4'-ethynyl-2-fluoro-2'-deoxyadenosine |
2'-脱氧-4'-C-乙炔基-2-氟腺苷 |
865363-93-5 |
QQ
微信
